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Kerensa McElroy1,2*, Osvaldo Zagordi3, Rowena Bull2, Fabio Luciani2† and Niko Beerenwinkel4,5†Abstract
Background: Deep sequencing is a powerful tool for assessing viral genetic diversity. Such experiments harness the
high coverage afforded by next generation sequencing protocols by treating sequencing reads as a population sample.
Distinguishing true single nucleotide variants (SNVs) from sequencing errors remains challenging, however. Current
protocols are characterised by high false positive rates, with results requiring time consuming manual checking.
Results: By statistical modelling, we show that if multiple variant sites are considered at once, SNVs can be called
reliably from high coverage viral deep sequencing data at frequencies lower than the error rate of the sequencing
technology, and that SNV calling accuracy increases as true sequence diversity within a read length increases. We
demonstrate these findings on two control data sets, showing that SNV detection is more reliable on a high diversity
human immunodeficiency virus sample as compared to a moderate diversity sample of hepatitis C virus. Finally, we
show that in situations where probabilistic clustering retains false positive SNVs (for instance due to insufficient sample
diversity or systematic errors), applying a strand bias test based on a beta-binomial model of forward read distribution
can improve precision, with negligible cost to true positive recall.
Conclusions: By combining probabilistic clustering (implemented in the program ShoRAH) with a statistical test of
strand bias, SNVs may be called from deeply sequenced viral populations with high accuracy.Background
Next generation sequencing technologies have unprece-
dented potential for assessing genetic diversity in viral pop-
ulations [1,2]. As compared to traditional Sanger bulk
sequencing, the cost per base of sequencing is low, due in
part to the massively parallel nature of these technologies
[3]. Roche-454 is currently the most popular technology to
investigate diversity in viral populations, thanks to its su-
perior read length compared to other platforms such as
Illumina GAIIx [4], but both technologies have advantages
and disadvantages for analysing viral diversity, suggesting
that experimental design should be planned carefully [5].
Currently, one run of Roche-454 sequencing can produce* Correspondence: kerensa@unsw.edu.au
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reproduction in any medium, provided the orone million reads, with a modal read length of 700nt -
enough to sequence five 10kb viral genomes to a coverage
of 20,000x each. This high coverage facilitates deep se-
quencing experiments, where reads are treated as a popu-
lation sample containing information about the underlying
genetic structure of the population. For example, deep se-
quencing has been used to study bottlenecks in early HCV
infection [6] and to identify mutations associated with drug
resistance in HIV [7,8].
A major challenge in deep sequencing experiments in-
volves separating true variants from sequencing errors.
Although average error rates are constantly improving,
error rates remain highly heterogeneous as they are af-
fected by sequence context (for instance, homopolymer
sequences) and alignment errors [9,10]. This means that
locally, error rates can still be quite high, leading to false
positive SNV calls [11].
A number of tools are available for calling SNVs
within the context of sequencing errors. However, most
approaches are tailored to calling SNVs in humanl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
McElroy et al. BMC Genomics 2013, 14:501 Page 2 of 12
http://www.biomedcentral.com/1471-2164/14/501resequencing projects and are not suitable for viral deep
sequencing data. When resequencing a human genome,
SNVs are either heterologous and can be expected to be
present in 50% of all reads, or homologous and should
be present in 100% of reads. Commonly, a probabilistic
approach is employed to decide whether a potential
SNV is either an error, a homologous SNV, or a heterol-
ogous SNV [12,13]. In deep sequencing experiments,
however, very low frequency SNVs, including SNVs
present in less than 1% of reads, are often of interest
[4,14]. For instance, the presence of low frequency vari-
ants in the viral population of a single host may deter-
mine the potential for drug resistance and treatment
failure [7,15].
To date, deep sequencing data has been analysed by
applying various read quality filters before and after
alignment and then further manually filtering the results,
according to the researcher’s understanding of the se-
quencing technology and the individual data set [16]. Fil-
tering may also be performed with a software program
such as VarScan [17], an SNV caller which relies on read
coverage, base qualities, and variant frequencies to sep-
arate true SNVs from errors. An emerging statistical
method for detecting SNVs in deep sequencing data in-
volves performing a statistical test for each potential
SNV, taking into account a prior positional error model
[18]. This method detected SNVs with a population fre-
quency of 0.1% in control Illumina data. However, the
requirement for a prior positional error model relies on
the availability of multiple replicates, which is not always
feasible.
A more recent approach to SNV detection in viral
populations, implemented in the program V-Phaser, uti-
lises the covariance between observed SNVs present on
the same read to increase sensitivity [19]. The power of
covariance was also harnessed in a recent study of HCV
early evolution, where SNV calling was achieved by pars-
ing haplotypes reconstructed using probabilistic cluster-
ing performed by the program ShoRAH [6]. ShoRAH
uses a Bayesian approach to group reads into haplotypes.
Both sensitivity and specificity are improved by assum-
ing that the consensus sequence for each cluster is the
true haplotype sequence; all other variants present in
the reads within a cluster are considered to be errors
[20,21]. ShoRAH has been shown to accurately recon-
struct variants with a population frequency of 0.1%, and
to efficiently remove random PCR errors [22]. Error cor-
rection via probabilistic clustering will fail, however,
when errors themselves appear clustered. This can occur
in regions of low diversity characterised by an absence of
true variants, or when sequencing errors are systematic
(e.g., in homopolymeric regions). The potential for sys-
tematic errors to confound clustering may explain why
an empirical k-mer based algorithmic approach wasfound to be more efficient than ShoRAH at removing
false haplotypes, although both approaches detected all
true haplotypes [23].
There is growing evidence that systematic errors may
exhibit a strand bias, where a particular error is more
likely to occur in reads traversing the genome in one dir-
ection as opposed to the other [24]. For instance, in a re-
cent analysis addressing errors from control Illumina
data using prior positional error models, error rates be-
tween forward and reverse reads were uncorrelated [18].
Because of this, several SNV detection methods consider
forward reads and reverse reads separately, using some
combination of the two obtained p-values to inform the
final SNV calling decision [18,25]. Researchers have also
used strand bias directly to filter out false positive SNVs.
For example, in a deep sequencing analysis of HIV-1
quasispecies, any potential SNVs with more than 10 fold
difference in the forward and reverse read count were
considered to be systematic errors [16], while in the
HCV study mentioned above, raw results from ShoRAH
were further cleaned by removing any potential SNVs
that showed a difference of more than 10% between the
number of forward and reverse reads [6]. The latest ver-
sion of Samtools formalises this approach, reporting a p-
value based on an exact test of strand bias [26]. A two
tailed Fisher’s exact test is also included in the recently
released SNV caller LoFreq [27].
Here, we show that in addition to its primary function
of haplotype reconstruction, ShoRAH may also be used
to reliably call SNVs. This is demonstrated through ana-
lysis of control Roche-454 data from both HCV and HIV
samples, and by development of a statistical argument in
support of SNV calling via probabilistic clustering. As
strand bias has been observed in systematic errors
retained during clustering [6], we also investigate the
benefits of combining probabilistic clustering with a stat-
istical test of strand bias.
Results
Our SNV calling method is based on two assumptions:
(1) it is more powerful to compare several variants that
co-occur on the same read simultaneously than indi-
vidually; and (2) the frequency of sequencing errors, but
not of true SNVs, is often higher on reads sequenced in
one direction than the other. While there is empirical
evidence for the second assumption, the first one can be
motivated and made precise by a simplified statistical
model of SNV detection (see Methods). In this model,
two haplotypes of frequencies f and 1 − f that differ at d
sites co-occurring within an observed read, can be dis-
tinguished in the presence of a per site error probability
ε only if (approximately) f > εd. For d = 1, this result con-
firms the intuitive notion that a single SNV can be
detected only if the error rate is smaller than the SNV
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(d = 2), then the probability that these two variants are
both errors is ε2, and the limit of haplotype detection de-
creases to f > ε2. In general, considering multiple variant
sites at once by comparing haplotypes increases SNV
calling accuracy (Figure 1). This finding motivates ana-
lysing entire reads or large segments of reads in order to
include as many SNVs as possible, as is done in read
clustering methods such as ShoRAH.
To investigate real life performance of SNV calling via
probabilistic clustering, we analysed Roche-454 data
from two distinct control experiments. For the first ex-
periment, the same library of cloned moderate-diversity
HCV fragments mixed at equal quantities was subjected
to two independent Roche-454 sequencing runs (HCV
run 1 and HCV run 2) [6]. For the second experiment,
one round of Roche-454 sequencing was performed on a
high diversity PCR amplified set of HIV fragments mixed
according to a geometric series [22].
SNVs were called using either probabilistic clustering
(ShoRAH), quality score based filtering (VarScan), or a per
site quality score based statistical test (LoFreq) [27]. A stat-
istical test of strand bias was applied to the results from
ShoRAH and VarScan, utilising either a beta-binomial (or
binomial) model of forward read distribution for true SNVs,
or Fisher’s exact test (LoFreq includes its own Fisher’s exact
test of strand bias). Our experimental design allowed us to
assess the performance of probabilistic clustering, and vari-






























Figure 1 Limit of SNV detection. Shown is the maximal error rate
ε at which SNVs of frequency f are detectable if d sites are analysed
simultaneously. In a simple model of SNV calling (see Methods), this
bound is εd < 1/[1 + (1 − f )/f ] ≈ f, giving rise to the lines of slope 1/d
for two haplotypes at Hamming distances d in the double
logarithmic plot.between samples with different diversity levels and between
individual sequencing runs.
Alignment and clone frequencies
For HCV run 1 and HCV run 2, 97.1% and 95.7% of reads
aligned uniquely to the reference, giving an average read
depth of 2564 reads and 3291 reads, respectively. For the
HIV data, 88.9% of reads aligned, giving an average read
depth of 6915 reads. True haplotype frequency estimates
are given in Table 1 (HCV) and Table 2 (HIV). For all
samples, the frequencies of at least some haplotypes dif-
fered substantially from their intended frequencies. As the
estimated frequencies for HCV run 1 and HCV run 2 are
very similar, it is likely that deviation from intended fre-
quencies is a result of mixing errors, rather than bias in-
troduced during library preparation and sequencing. Lists
of true SNVs for both HCV and HIV samples are provided
in the Additional files 1 and 2.Raw SNV calls
For HCV run 1 and HCV run 2, both ShoRAH and
VarScan detected all true SNVs, i.e. the false negative rate
was zero (Table 3), while LoFreq called all but one true
SNV in each run. VarScan, however, also called up to 206
(run 1) and 826 (run 2) false positives, more than seven
times as many as ShoRAH. More errors were incorrectly
identified as SNVs for HCV run 2 compared to HCV run
1 by both VarScan and ShoRAH, indicating a higher error
rate for HCV run 2. VarScan’s recall was greater than
ShoRAH’s for the HIV data, with 93% of true SNVs identi-
fied, compared to 81% for ShoRAH. However, ShoRAH’s
recall was greater than LoFreq’s, which only identified 64%
of true SNVs.
For the HIV sample, all of ShoRAH’s false negatives
had true population frequencies under 0.5%, while one
of VarScan’s false negatives had a true population fre-
quency of 11.9% (see also Figure 2a: recall values less
than one indicate false negatives). Upon inspection of
the alignment and the VarScan file, this appeared to be
the result of confusion in reporting positions with more
than one variant allele. Most of LoFreq’s false negatives
were very low frequency (under 1%), with three having
true population frequencies of under 6%. VarScan’sTable 1 Estimated true and intended clone frequencies,
HCV
Clone Intended (%) True, run 1 (%) True, run 2 (%)
023-180,609-2 25.0 37.1 39.2
023-180,609-1 25.0 25.9 24.7
023-180,609-6 25.0 25.0 24.3
023-180,609-5 25.0 12.0 12.0
Table 2 Estimated true and intended clone frequencies,
HIV
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false positive calls – over the reference 766bp consid-
ered, 732 false positive SNVs were also called. By com-
parison, ShoRAH only made two false positive calls
(Table 3 and Figure 2b). Overall, LoFreq exhibited anTable 3 SNV calling accuracy
Data set Method ShoRAH V
TP FP FN Rc. Pr. T
HCV1 Raw 38 29 0 1.000 0.567 3
Fisher’s exact 32 6 6 0.842 0.842 3
Bin. (σ = 0) 37 7 1 0.974 0.841 3
B-bin., σ = 0.0004 37 7 1 0.974 0.841 3
B-bin., σ = 0.0014 37 8 1 0.974 0.822 3
B-bin., σ = 0.0111 38 8 0 1.000 0.826 3
HCV2 Raw 38 50 0 1.000 0.432 3
Fisher’s exact 33 9 5 0.868 0.785 3
Bin. (σ = 0) 34 8 4 0.895 0.810 3
B-bin., σ = 0.0004 36 8 2 0.947 0.818 3
B-bin., σ = 0.0014 36 8 2 0.947 0.818 3
B-bin., σ = 0.0111 38 13 0 1.000 0.745 3
HCV2 Raw 153 2 35 0.814 0.987 1
Fisher’s exact 87 0 101 0.462 1.000 1
Bin. (σ = 0) 88 0 100 0.468 1.000 1
B-bin., σ = 0.0004 101 1 87 0.537 0.990 1
B-bin., σ = 0.0014 126 1 62 0.670 0.992 1
B-bin., σ = 0.0111 151 2 37 0.803 0.987 1
SNV calling statistics for ShoRAH, VarScan, and LoFreq. For ShoRAH and VarScan, SN
beta-binomial dispersion parameter σ in the strand bias test are given, with σ = 0 c
applying our strand bias test are absent as this software does not report forward an
Fisher’s exact test to the raw output are also given (this was possible for LoFreq as
statistics include true positives (TP), i.e., genomic sites with a variant matching a kn
not a known true variant, and false negatives (FN), i.e., known variants which are no
contribute to both true positives and false positives. Recall (TP/(TP + FN)) and precisexceptionally low false positive rate. For the HCV runs,
one unique false positive was identified in each run,
while no false positives were called by LoFreq for the
HIV data.Strand bias test
In an attempt to improve ShoRAH’s performance under
conditions of sub-optimal diversity or clustered system-
atic errors, we applied a statistical test of strand bias to
the raw SNV calls.
For each potential SNV detected, we test the hypothesis
that the distribution of forward reads carrying this SNV
follows a beta-binomial distribution, with mean value
equal to the overall forward read distribution at that pos-
ition. The overdispersion of the forward read distribution
is controlled by the parameter σ, which we estimate separ-
ately for each sequencing run using maximum likelihood
(ML) methods based on the observed forward read distri-
bution for all true SNVs within the sample (see Methods).
ML estimates of σ for HCV run 1, HCV run 2, and HIV
samples were 0.0004, 0.0014, and 0.0111 respectively. ToarScan LoFreq
P FP FN Rc. Pr. TP FP FN Rc. Pr.
8 206 0 1.000 0.156 37 1 1 0.974 0.974
6 179 2 0.947 0.167 29 0 9 0.763 1.000
6 108 2 0.947 0.250
7 108 1 0.947 0.255
7 108 1 0.947 0.255
8 108 0 1.000 0.261
8 826 0 1.000 0.044 37 1 1 0.974 0.974
6 766 2 0.947 0.045 29 0 9 0.763 1.000
5 577 3 0.921 0.057
6 577 2 0.947 0.059
6 577 2 0.947 0.059
8 589 0 1.000 0.061
75 732 13 0.931 0.193 121 0 67 0.644 1.000
25 671 63 0.665 0.157 41 0 147 0.218 1.000
13 473 75 0.601 0.193
21 474 67 0.644 0.203
35 475 53 0.718 0.221
62 490 26 0.862 0.248
V calls without the strand bias test (Raw) and using different values of the
orresponding to a binomial forward read distribution. For LoFreq, the results of
d reverse strand counts. For all SNV calling methods, the results of applying
it reports a strand bias Fisher’s exact test p-value for each variant). Reported
own true variant, false positives (FP), i.e., genomic sites with a variant that is
t identified by the relevant SNV calling method. Individual genomic sites may





Figure 2 SNV recall and false positives by frequency. Detailed analysis of SNV calling for variants with population frequency less than 15%.
Both raw results, and results subjected to a strand bias test with σ=0.0111, are given. In cases where cross hairs fill a symbol of the same colour,
the strand bias test had no effect on results. (a) Recall of true SNVs for HIV data, by frequency (calculated using known haplotype frequencies
(see Table 2)). Note: for SNVs with population frequency greater than 15%, recall was perfect for all methods. For this reason, recall plots for HCV1
and HCV2 are also omitted, as they are straight lines with perfect recall = 1. (b) HIV, (c) HCV run 1, and (d) HCV run 2, absolute false positive SNV
counts by predicted frequency for each method, binned in intervals of 1%. A double logarithmic scale is used for plots (b), (c), and (d); thus data
points where no false positives are recorded are omitted. For all ShoRAH runs, no false positives were observed with population frequency
greater than 15%. Some false positives with population frequency greater than 15% occurred for the VarScan runs, however close inspection
revealed the majority of these to be the result of a VarScan bug when calling SNVs for genomic positions with two or more variants.
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values of σ to each dataset, also performing a test with σ=0
(corresponding to a binomial forward read distribution).
For comparison with the strand bias test implemented in
other software, we also performed a Fisher’s exact test of
strand bias.
SNV calling statistics for strand bias tests applied to the
raw results of both ShoRAH and VarScan are given in
Table 3. The results of LoFreq’s own implementation of
Fisher’s exact test are also given. Applying a strand bias
test to the raw SNV calls for both ShoRAH and VarScan
improved precision in all cases, except for HIV SNV calls
made using ShoRAH with σ = 0.0111, where precision
remained unaltered compared to the raw ShoRAH output.
In general, choice of σ did not have a substantial impact
on precision. However, smaller values of σ were morelikely to result in reduced recall, as was Fisher’s exact test.
Recall was also compromised by LoFreq’s implementation
of Fisher’s exact test. This was particularly evident for the
HIV data, and is consistent with an overdispersed forward
read distribution for true SNVs, justifying our choice of a
beta-binomial forward read distribution.
For the beta-binomial test, the reduction in recall was
minimised in all cases by using σ = 0.0111. To further in-
vestigate the appropriateness of a beta-binomial based
strand bias test (with σ = 0.0111), compared to either a bi-
nomial based test or Fisher’s exact test, we generated pre-
cision recall curves for each test applied to SNV calls from
ShoRAH and VarScan (Figure 3). In all cases, across the
full range of recall values obtained the beta-binomial test
gave equivalent or higher precision than either of the
other tests, confirming its suitability.
(a) HCV1, ShoRAH














































































Figure 3 Precision recall curves for various strand bias tests. Precision versus recall, for strand bias tests performed on raw SNV calls from
(a) ShoRAH applied to HCV run 1, (b) VarScan applied to HCV run 1, (c) ShoRAH applied to HCV run 2, and (d) VarScan applied to HCV run 2. In
all cases, strand bias tests based on an underlying beta-binomial forward read distribution exhibited greater or equal precision for the same recall
value, when compared to either a strand bias test with a binomial forward read distribution, or a Fisher’s exact test of strand bias.
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good at reducing errors in results from ShoRAH, with more
than 70% of errors eliminated. After the strand bias test, less
than six errors for every 1000 reference sites remained for
HCV run 2, while less than four errors for every 1000 refer-
ence sites remained for HCV run 1. The strand bias test also
eliminated 48% of errors in VarScan’s output, however as
VarScan’s raw output contained more errors than ShoRAH,
this still left a minimum of 47 errors for every 1000 refer-
ence sites. LoFreq’s strand bias test successfully eliminated
the single false positives originally identified in HCV run 1
and HCV run 2.
Figure 2 presents a detailed analysis of SNV calling by fre-
quency for VarScan and ShoRAH, for SNVs with frequen-
cies less than 15%. LoFreq results are excluded from this
analysis, due to its near perfect precision for all data sets.
Figure 2a shows that for the high diversity HIV data, perfect
recall could be achieved for SNVs with population frequency
greater than around 0.5%. Any reduction in recall due to the
strand bias test was limited to SNVs with frequencies belowthis detection limit. Thus, although consideration of both re-
call and precision indicates the strand bias test does not im-
prove on the raw HIV ShoRAH results, it is not significantly
detrimental. The lack of improvement is due in part to the
extremely high precision of 0.987 obtained by probabilistic
clustering alone (see Table 3 and also Discussion).
For the HIV VarScan results, although the strand bias
test did increase precision, more than 617 errors for every
1000 reference sites remained. Figure 2b indicates that this
is the result of low frequency false positives. Restricting
SNV calls to those covered by a minimum of 10 reads
therefore rectified this problem to some extent (data not
shown), however over 207 errors for every 1000 reference
sites were retained. Recall was also adversely affected, due
to the presence of very low frequency true SNVs in the
HIV sample. Using a minimum read coverage of 10 had
no effect on HIV ShoRAH results.
Figures 2b to 2d describe the number of false positives
observed for each data set, binned in frequency incre-
ments of 1%. In general, ShoRAH calls less false positives
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(< 1%). In most cases, the strand bias test was able to re-
duce or eliminate false positives across the range of fre-
quencies observed (in Figure 2b-d, if the cross hairs are
lower than the corresponding square or circle of the same
colour, then the strand bias test reduced the false positive
rate within the corresponding frequency bin). The effect-
iveness of the strand bias test was most notable for
ShoRAH SNV calls from the moderate diversity HCV
samples.
Discussion
We have shown that SNV calling via probabilistic clus-
tering is a powerful technique allowing detection of
SNVs at frequencies lower than the corresponding se-
quencing error rate, as long as sample diversity is high
(i.e., two or more true SNVs can be expected to occur
within an observed read) and errors are random. When
these conditions are not met, a statistical test of strand
bias improves SNV calling precision.
The distribution of forward reads covering a true SNV
at any one position could be expected to follow a bino-
mial distribution, with mean value equal to the fraction
of forward reads at that position multiplied by the total
number of reads covering the variant. However, our re-
sults show that more accurate SNV calling is achieved if
the expected number of forward reads is modelled using
a beta-binomial read distribution, compared to either a
binomial distribution or applying Fisher’s exact test.
Variation in the number of false positives between the
HCV runs indicated error rates differed markedly, even
though all samples were sequenced using Roche-454 Ti-
tanium technology. Notably, the ability to utilise empir-
ical run specific error rates was one of the motivating
factors behind LoFreq’s development. A similar result
has been reported for Illumina sequencing as well, with
individual runs sequenced on the same machine having
dissimilar error profiles [11]. SNV calling precision after
strand bias testing was relatively robust to choice of dis-
persion factor σ. Using a very low value of σ, however,
compromised SNV recall, thus we would recommend
choosing a value of σ closer to our upper estimate of
0.0111 when applying our test to real data.
For this reason, σ is set to 0.01 by default in our
updated version of ShoRAH (σ is the only additional
user specified parameter introduced to ShoRAH as a re-
sult of the strand bias test – all other parameters are es-
timated directly from the user’s data). For the HCV
samples, which featured a moderate number of relatively
high frequency true SNVs, the beta-binomial strand bias
test provided a substantial reduction in error rates with
no cost to true positive recall. This was true when ap-
plied to both the raw ShoRAH output and the raw
VarScan output. However, both the relative reduction inerror and absolute precision attained was greatest when
the test was applied to the raw ShoRAH output. Unfortu-
nately, it was not possible to apply our beta-binomial
strand bias test to LoFreq’s raw SNV calls, as variant
counts by forward and reverse read are not given in
LoFreq’s output. LoFreq’s own Fisher’s exact test of strand
bias successfully removed all false positives, however it
also removed a number of true positives. Given the results
reported here, we believe that a beta-binomial strand bias
test may also remove these false positives, with substan-
tially less cost to true positive recall.
For the HIV sample, the raw ShoRAH output gave the
best results. This can be explained by the extremely
strong performance of error correction via probabilistic
clustering in this case. The ability to correctly identify
true haplotypes via probabilistic clustering (and there-
fore the SNVs contained within the haplotypes) is a
function of the frequency of the haplotypes, the number
of variant positions within the haplotypes, and the error
rate of the sequencing technology (see Methods). When-
ever there is more than one true variant within a haplo-
type under consideration, it becomes possible to detect
SNVs with population frequencies below the error rate
of the sequencing technology. Consideration of HIV false
positives called using VarScan indicates that locally, error
rates may exceed 5%. For the HIV data, we achieved a de-
tection limit well below this local error rate using ShoRAH
alone, validating our argument. Figures 2a and 2b show
that perfect accuracy (recall of one, with zero false posi-
tives) can be achieved by applying a detection limit of
3%, while a detection limit of only 0.5% gives perfect recall
with only two false positives.
Another implication of our model is that accuracy
should improve as the number of SNVs within a window
of sites considered simultaneously increases, as demon-
strated by the fact that ShoRAH performs better on the
intrinsically high diversity HIV sample than on the mod-
erate diversity HCV samples. Our argument is further
supported by VarScan’s performance. Although for the
HIV sample VarScan detected more true positives than
ShoRAH, the corresponding extremely large number of
low frequency false positives within the VarScan results
suggests that this is the result of only considering one
site at a time and indiscriminately calling low frequency
SNVs below the associated detection limit (i.e., the local
sequence error rate). LoFreq’s approach of discriminat-
ing SNVs individually by inferring an error probability
based on the quality score assigned to individual nucleo-
tides clearly overcomes this problem, although at the ex-
pense of recall.
While our strand bias test could not improve ShoRAH’s
raw SNV calls for the HIV sample, we consider the slight
reduction in recall with σ = 0.0111 (two additional very
low frequency true SNVs were classified as errors) to be
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the test. It is usually not possible to know, a priori, how di-
verse a deep sequenced population may be. Even within
highly diverse populations, genomic regions under purify-
ing selection may have sub-optimal levels of diversity,
allowing errors to appear clustered as true SNVs. Our
strand bias test can help remove such errors, while leaving
SNV calls in highly diverse regions relatively untouched.
Our strand bias test could also be used to provide a level
of confidence in results. If SNV calls are unaffected by ap-
plying a strand bias test, as in the case of our HIV sample,
then it is likely that diversity was sufficient for probabilistic
clustering to perform at its best.
Applying our strand bias test to raw VarScan SNV calls
also improved precision in all cases. However, false positive
SNV calls could not be reduced to a biologically useful
level. The relative advantage of applying a strand bias test
to ShoRAH’s output compared to VarScan’s output can be
understood by considering how each of these programs
identifies SNVs. VarScan distinguishes errors from true
SNVs by examining the individual base quality scores of
reads covering the potential SNV. VarScan is therefore reli-
ant on accurate assignment of quality scores during the se-
quencing platform’s base calling pipeline. If an error
nucleotide is falsely assigned a high quality score, then
VarScan will retain it. Although LoFreq is also dependent
on quality scores assigned by the sequencing platform, it
has some resilience to this effect as quality information
from all aligned nucleotides at a position is considered
when making a call; errors at a given position would have
to systematically be assigned high quality scores for LoFreq
to incorrectly call an SNV. In contrast to VarScan, ShoRAH
is independent of quality score information. ShoRAH works
by removing any potential SNVs that are randomly distrib-
uted among reads, rather than clustering with nearby po-
tential SNVs - regardless of whether they occurred during
library preparation, PCR amplification, or read synthesis.
Errors retained during clustering are likely to be systematic
sequencing errors, which tend to exhibit a strand bias.Methods
Statistical analysis of SNV calling based on probabilistic
clustering
SNV calling from ShoRAH output involves parsing a set of
‘haplotypes’ for variants with respect to a reference se-
quence. These haplotypes are generated by deriving con-
sensus sequences from groups of probabilistically clustered
aligned reads. Because only the consensus sequence within
each cluster is considered, SNVs will be correctly called,
provided reads are correctly clustered so that the haplo-
types can be identified from the centroids of the clusters.
The detection limit for true SNVs therefore depends on
the detection limit for haplotypes. The detection limit forhaplotypes is the haplotype frequency at which observed
variants are equally likely to be errors (co-occurring within
reads due to chance) or biological variants (corresponding
to a true haplotype). For example, if two haplotypes differ
at only one site (i.e., they have a Hamming distance of
one), then the detection limit is intuitively equal to the
error rate, ε. If, however, the haplotypes differ at two sites
(with Hamming distance of two), then it takes two specific
sequencing errors to mutate a read originating from one
haplotype into a read that is equal to the other haplotype.
This occurs with a probability of the order ε2. Now, ε2 < ε,
allowing haplotypes (and consequently SNVs) to be
detected at frequencies lower than the error rate provided
two sites are considered simultaneously (this has been
exploited, for example, in [19]).
To investigate this property more formally, we study the
probability of correctly assigning a read to either of two
haplotypes: a minor haplotype with frequency f containing
the same variants as the read under consideration, and a
major haplotype (representing the next most similar pre-
existing reconstructed haplotype) with frequency 1 − f . To
simplify our analysis, we consider only those sites where
these two haplotypes differ, as other sites are uninformative
when choosing which haplotype to assign the read to.
According to this model, the major and minor haplotypes
may be represented by the binary sequences 0− = 000 . . .
0 and 1− = 111 . . . 1 of length d, where d is the Hamming
distance between these two haplotypes. Now, let the ran-
dom variable H = (H1, . . . , Hd) denote the true haplotype,
such that P(H = 0−) = 1 − f and P(H = 1−) = f . Observation
errors are assumed to occur independently with uniform
per site probability P(Ei = 1) = ε, where each random vari-
able Ei indicates the occurrence of an error at site i. The
observed read, Y, is the true haplotype H subject
to observation error: Yi = 0 if (Hi, Ei) = (0, 0) or (1, 1), and
Yi = 1 otherwise. The full model is defined as follows:
H ∼ Bernoulli fð Þ; H∈ 0 ; 1f g
Ei ∼ Bernoulli εð Þ; Ei∈ 0; 1f g; i ¼ 1; :::; d
Y i ∼ Hi þ Ei mod2; i ¼ 1; :::; d:
ð1Þ
In particular, P (Y = 1− | H = 0−) = ε
d and P (Y = 1− |
H = 1−) = (1 − ε)
d.
In order to assign the read correctly, we need to decide
whether the observed read, Y = 1−, is more likely to origin-
ate from the minor haplotype H = 1− without error or from
the major haplotype H = 0− through (multiple) errors. This
decision represents a crucial step in the iterative probabil-
istic assignment of reads to haplotypes within ShoRAH –
if the constituent reads of a low frequency true haplotype
are just as likely to originate from a higher frequency
haplotype through sequencing errors, then they may be in-
correctly assigned to the higher frequency haplotype. In
this case, the low frequency haplotype falls below the limit
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final set of clustered reads.
Based on this model, the assignment will be correct if:
P H ¼ 0 Y ¼ 1j Þ < P H ¼ 1 Y ¼ 1j Þ:ðð ð2Þ
Using Bayes’ theorem and Eqs. 1, this inequality be-
comes εd(1 − f ) < (1 − ε)df, or
ε < 1þ 1−f
f
 1=d" # −1
: ð3Þ
For noise levels ε below this upper bound, we would
assign the reads correctly. For d = 1, the condition is ε <
f, and for ε and f small, it is approximately εd < f. Thus
for a given per nucleotide sequencing error rate, the fre-
quency limit for haplotype detection decreases as the
number of true SNVs observed within a read increases.
In reality, the process of haplotype inference is of course
more complicated than presented here – our simplified
argument is designed to merely demonstrate in a quantita-
tive way that by observing the co-occurrence of variant
sites, more power can be achieved when calling low fre-
quency haplotypes (and hence SNVs) than by considering
variant sites independently.
Strand bias test
We assume that at any given genomic position, the number
of forward reads carrying a variant follows a beta-binomial
distribution. More formally, let Fi and Ri, respectively, de-
note the total number of forward and reverse reads cover-
ing position i. The fraction of forward reads is μi = Fi/(Fi +
Ri). We define nib as the total number of reads (forward
and reverse) covering the variant base b at sequence pos-
ition i. The number of forward reads carrying variant b at
position i is modelled by the beta-binomial random variable
Xib~BetaBin(nib, μi, σ) such that 0 ≤ Xib ≤ nib and
P Xib ¼ xð Þ ¼ Γ nib þ 1ð Þ
Γ xþ 1ð ÞΓ nib−xþ 1ð Þ
 Γ 1=σð ÞΓ xþ μi=σð ÞΓ nib þ 1−μið Þ=σ−xð Þ
Γ nib þ 1=σð ÞΓ μi=σð ÞΓ 1−μið Þ=σð Þ
ð4Þ
The expected value of Xib is E(Xib) = nibμi, and σ is a
dispersion parameter, defined such that





The dispersion parameter σ determines the spread of
the distribution. We assume that, unlike nib and μi, σdoes not change between each variant within a sample.
Both nib and μi can be easily estimated directly from the
data for each individual potential SNV under question.
We employed ML estimation to obtain σ estimates for
each sample, by considering the K true SNVs xi1b1 ;…;
xikbk . The likelihood function is:
L σð Þ ¼
YK
j¼1
P Xijbj ¼ xijbj
 
: ð6Þ
ML estimation was performed in R with the package
mle2, using the default Nelder and Mead optimisation
method and a start value of one. (Per-sample ML estima-
tion of σ was only possible as this study employed control
data with known SNVs. For real data, we suggest using a σ
of around 0.01, close to our highest estimate of σ from our
control data. Our analysis indicated that results are fairly
stable with respect to σ).
Our null hypothesis, H0, is that for any given true
SNV, the number of forward reads follows a beta-bino-
mial distribution with parameters μ, n, and σ. The null
hypothesis H0 is rejected if, under H0, the probability to
observe data as extreme or more extreme than that ob-
served is smaller than a threshold p. That is, given an
observation xib, we reject H0 if min {Φ(xib), 1 − Φ
(xib)} × 2 < p, where Φ(xib) = P(Xib ≤ xib) is the beta-
binomial cumulative distribution function (calculated in
R using the gamlss beta-binomial CDF), with parameters
estimated as described above.
If, for a potential SNV, the null hypothesis is rejected,
then the potential SNV is considered to be an error. As
we do not care which direction the strand bias occurs
in, a two-sided test was performed by multiplying the
smallest tail of Φ(Xib) by two. We then applied the
Benjamini-Hochberg correction for multiple testing, giv-
ing the final p-value p. If p < 0.05, we reject the potential
variant as an error.
To investigate the effect of σ on the strand bias test
(in particular the possibility of overfitting), strand bias
tests with each estimate of σ were applied to SNV calling
results obtained from ShoRAH and VarScan for all data
sets. A test with σ = 0 was also performed, which models a
binomial forward read distribution. For comparison, two-
sided Fisher’s exact tests were also applied, based on
counts of the forward and reverse reads, again with a
Benjamini-Hochberg correction for multiple testing. It
was not possible to apply our strand bias test to SNV calls
from LoFreq, as LoFreq’s output does not record the num-
ber of forward and reverse reads covering a variant.
LoFreq does however report a p-value based on a Fisher’s
exact test of strand bias. Thus we were able to report the
results of a Fisher’s exact test of strand bias applied to raw
LoFreq SNV calls, again applying a Benjamini-Hochberg
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variants for which p < 0.05.
To further compare the performance of Fisher’s exact
test, a binomial strand bias test, and our beta-binomial test
(with σ = 0.0111), precision recall curves were constructed
within R for each test applied to ShoRAH or VarScan
SNV calls from HCV run 1 and HCV run 2. This was
done by calculating the precision and recall for p-value
cut offs varying between zero and one (in increments of
0.005) and plotting the results.
Sample sequencing, alignment, and frequencies
For HCV E1/E2 samples, a mixture of four different
2324bp fragments (excluding primer regions), each cover-
ing the 3′ end of the HCV core to the 5′ end of the p7 re-
gion was cloned into the pGEM-T Easy vector and
sequenced using Roche-454 FLX Titanium as described
previously (HCV run 1) [6].
To investigate variation in σ between sequencing runs, a
second round of Roche-454 FLX Titanium sequencing
was performed on this same library of HCV clone mix-
tures (HCV run 2). For the HIV gag/pol-gene fragments,
10 PCR products from subtype-B clinical isolates were
propagated within the pCRII-TOPO vector, excised, and
subjected to a single round PCR before Roche-454 FLX
Titanium sequencing, as previously described [22].
Prior to alignment, reads were trimmed using a sliding
window of 8nt. The trim was made at the start of the first
8nt window from either end with an average quality greater
than 20. For all samples, alignment was performed using
bwasw [28], with default parameters. For the HCV samples,
alignment was performed against the entire pGEM genome
with an HCV 1a strain insert, corresponding to the
inserted fragments [6]. For the HIV sample, alignment was
performed against the appropriate region of the HXB2
HIV reference genome, from base 2253 to 3497.
To estimate the true frequency of each fragment
within the mixture, the known sequences of each frag-
ment were used to locate SNV positions uniquely identi-
fying each fragment. Fragment frequencies were then
calculated by averaging the frequency of all SNVs unique
to a fragment haplotype, then normalising the results so
that the sum of all haplotype frequencies was one.
SNV calling
ShoRAH 0.6 was run on all three alignments described
above. For each run, α was set to 0.01, window size was
set to 360 with a step size of 120, and the number of it-
erations to 15 times the window coverage for each win-
dow. To call an SNV from the raw ShoRAH output,
locally reconstructed windows were parsed for variant
positions. For an SNV to be called, the same variant was
required to be found in at least two of three overlapping
windows, with a posterior probability greater than 0.9.This approach was compared to single site SNV calling,
as implemented in LoFreq and VarScan. LoFreq is a single
site variant caller that uses per nucleotide quality score in-
formation to inform a statistical test for each potential
SNV. LoFreq is tailored to calling low frequency variants
in deep sequencing data, and is thus ideally suited to iden-
tifying variants in viral populations. SNV calling was
performed using the script lofreq_snpcaller.py (v0.6.0)
with default options. VarScan was also employed due to
its ability to report the required read statistics for the
strand bias test, and its single site mode of SNV calling.
However, we acknowledge that VarScan is intended for
use on diploid resequencing data rather than deep sequen-
cing of viral populations, and do not imply that results
reported here are indicative of performance under normal
usage conditions. VarScan’s pileup2snp command (v2.2.3)
was used to call SNVs. Default values for quality filtering
were used. Minimum variant frequency was set to zero, to
allow comparison with ShoRAH. For all variant callers
employed, we limited called variants to those covered by
more than one read. To allow a fair comparison, SNV call-
ing using LoFreq and VarScan was only attempted in areas
of the genome covered by three ShoRAH windows. This
corresponds to positions 18 to 2324 of the HCV fragments
(2307 bp in total), and positions 240 to 1005 of the HIV
fragments (766 bp in total). In total, 38 true SNVs were
analysed for the HCV samples, and 188 true SNVs were
analysed for the HIV sample.
An attempt to call SNVs using V-Phaser was made, as
this program combines joint SNV calling with quality
score based methods. However, the program crashed
when used on any of our samples, possibly due to the high
coverage of samples. Correspondence with the authors did
not resolve the issue, thus the comparison was not able to
be made. SNV calling was also attempted using an empir-
ical k-mer based algorithm (‘Kec’) [23]. After running for
more than 150 cpu hours, this software did not produce a
result, at which point this comparison was also aban-
doned. SNV calling with DeepSNV [25] and using the ap-
proach described by Flaherty et al. [18] was not attempted
due to the lack of control or multiple samples.
For ShoRAH and VarScan, raw results, as well as results
subjected to our strand bias test, are reported. For the
purposes of this paper, all strand bias tests were performed
in R as described above. This was done to facilitate an
exact comparison between VarScan and ShoRAH results.
However, in conjunction with this manuscript we have re-
leased a new version 0.6 of ShoRAH with integrated SNV
calling and strand bias testing, which does not require R.
Conclusions
We have demonstrated that by combining probabilistic
clustering with a statistical test of strand bias, highly ac-
curate SNV calling can be achieved. This is because the
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complementary: probabilistic clustering relies on errors
occurring randomly and independently, while strand bias
tests detect systematic errors with atypical read direction
distributions.
Using a statistical model and through analysis of control
data we investigated the conditions under which probabil-
istic clustering can be used to call SNVs. We show that
the limit of SNV detection is εd < f, where ε is the rate of
randomly occurring sequencing errors, d is the number of
true variants observed within a read length, and f is the
frequency of the haplotype to which the variants belong.
In general, the SNV detection limit decreases as true di-
versity increases. This is consistent with our empirical
analysis of SNV calling from control data with various di-
versity levels. Importantly, for SNV calling via probabilistic
clustering to have an advantage over approaches that con-
sider individual variants one at a time, more than one true
variant must be contained within a read length.
To insure against situations where diversity is inad-
equate or errors are non-random, we suggest a strand
bias test be applied to SNV calls generated via probabil-
istic clustering. The test we propose uses a beta-
binomial model of forward read distribution for true
SNVs. By comparing our test to the performance of ei-
ther Fisher’s exact test or a test based on a binomial
model of forward read distribution, we show that the
forward read ratio of true SNVs is overdispersed. Our
analysis indicates that as long as this overdispersion is
taken into account, a statistical test of strand bias will
not affect recall. This means such a test can be safely ap-
plied and will not adversely affect accuracy, even in situ-
ations where no improvement in precision is obtained.
While our analysis is presented in the context of SNV
calling using ShoRAH, the insights into SNV calling via
probabilistic clustering should be applicable to any
method that considers multiple variant sites simultan-
eously. Furthermore, our strand bias test has the poten-
tial to improve SNV calling precision for any variant
detection pipeline.
Availability
The SNV caller and strand bias test have been integrated
into ShoRAH 0.6, available at http://www.cbgethz.ch/
software/shorah. Haplotypes, aligned reads, and refer-




Additional file 1: Tab delimited list of true SNVs for HCV
haplotypes. Format: Position \t Reference nucleotide \t Variant
nucleotide \t Frequency run 1 \t Frequency run 2. To facilitate analysiswith supplied reference sequences and alignments, position is given with
respect to the start of the vector; subtract 222 to get position with
respect to the HCV fragment. Frequencies are calculated based on the
estimated true frequency of haplotypes (Table 1).
Additional file 2: Tab delimited list of true SNVs for HIV
haplotypes. Format: Position \t Reference nucleotide \t Variant
nucleotide \t Frequency. Frequencies are calculated based on the
estimated true frequency of haplotypes (Table 2).
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